Please check this page regularly for the latest information. To receive these media updates, please email mediacontact@questdiagnostics.com.
January 2023
Subject Matter Expert of the Month: Dr. Michael K. Racket, Medical Director, Neurology
Dr. Michael K. Lukke A leader in the fields of neurology and neuroimmunology with over 30 years of leadership experience in academia and clinical practice. Dr. Racke’s expertise includes supporting the development of clinical tests to identify and monitor therapeutic response in neurological disorders such as: Alzheimer’s disease When multiple sclerosis. This includes providing expertise in developing the blood test Quest, which was launched last year to help assess risk for Alzheimer’s disease.Dr. Rake has authored over 200 peer-reviewed articles, book chapters, and reviews on the etiology of neuroimmune diseases, and has served on the editorial boards of numerous peer-reviewed journals, including JAMA Neurology. To schedule an interview, please email mediacontact@questdiagnostics.com.
1 in 2 Patients Tested for Prescription Drug Misuse, Discovers 10th Annual Quest Diagnostics Health Trends® Annual Report
Quest Diagnostics recently released its latest Health Trends® report, Substance Abuse in America 2022: The Lost Decade in the Drug Crisis. Based on insights from over 20 million anonymized clinical drug tests* over a decade, this report shows that despite progress made over the past decade, many patients of all ages and genders are still prescribing. It is clear that he is misusing the drug. By 2021, nearly half (49%) of patients prescribed opioids, benzodiazepines, amphetamines, and other controlled substances by their physicians will be at risk based on clinical drug results, compared to 60% in 2012. showed signs of drug combination or other forms of misuse. Over the past decade his use has surged fivefold and his use of dangerous drugs has increased. The report is a reminder that while illicit fentanyl is responsible for most overdose deaths, misuse of regulated medicines continues to be a public health challenge.
Quest Diagnostics and Northern Light Health Form Strategic Laboratory Collaboration to Improve Access to Affordable Diagnostic Services in Maine
Under a definitive agreement, Quest will acquire select assets of Northern Light Health’s outreach lab services business, including nine Northern Light Health hospital laboratories and a cancer center laboratory in Brewer, Maine. manage. Through this partnership, physicians and patients across Maine will have access to Quest’s industry-leading, highly innovative menu of tests, a statewide network of patient access sites, broad health insurance coverage, and many more services. You can benefit from a reduction in your out-of-pocket costs.
Quest supports underserved communities in the Mississippi Delta
Through its Quest for Health Equity (Q4HE) initiative, Quest recently provided free preventive health benefits to approximately 80 people attending the 8th Annual I-HEAL Community Wellness Day in Cleveland, Mississippi by the nonprofit Glenn Family Foundation. provided a diagnosis. Its mission is to improve life outcomes for children, youth and families in the Mississippi Delta by reducing health inequalities. Quest also provided funds to help purchase nutritious food boxes to share with event attendees. Over 700 attendees from across the region attended the event, which featured access to fresh fruit and vegetables, flu shots, COVID-19 home testing, immunizations, and blood pressure screening.
